These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11588103)

  • 1. The role of the hydrophilic Asn230 residue of the mu-opioid receptor in the potency of various opioid agonists.
    Pil J; Tytgat J
    Br J Pharmacol; 2001 Oct; 134(3):496-506. PubMed ID: 11588103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serine 329 of the mu-opioid receptor interacts differently with agonists.
    Pil J; Tytgat J
    J Pharmacol Exp Ther; 2003 Mar; 304(3):924-30. PubMed ID: 12604666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of p-fluorofentanyl on cloned human opioid receptors and exploration of the role of Trp-318 and His-319 in mu-opioid receptor selectivity.
    Ulens C; Van Boven M; Daenens P; Tytgat J
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1024-33. PubMed ID: 10945855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine-6beta-glucuronide and morphine-3-glucuronide, opioid receptor agonists with different potencies.
    Ulens C; Baker L; Ratka A; Waumans D; Tytgat J
    Biochem Pharmacol; 2001 Nov; 62(9):1273-82. PubMed ID: 11705461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional couplings of the delta- and the kappa-opioid receptors with the G-protein-activated K+ channel.
    Ikeda K; Kobayashi T; Ichikawa T; Usui H; Kumanishi T
    Biochem Biophys Res Commun; 1995 Mar; 208(1):302-8. PubMed ID: 7887943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of clozapine on the delta- and kappa-opioid receptors and the G-protein-activated K+ (GIRK) channel expressed in Xenopus oocytes.
    Kobayashi T; Ikeda K; Kumanishi T
    Br J Pharmacol; 1998 Feb; 123(3):421-6. PubMed ID: 9504382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and electrophysiological characterization of cyclic morphiceptin analogues.
    Pil J; Van der Veken P; Bal G; Augustyns K; Haemers A; Tytgat J
    Biochem Pharmacol; 2004 May; 67(10):1887-95. PubMed ID: 15130765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G protein-coupled receptor kinase 2 mediates mu-opioid receptor desensitization in GABAergic neurons of the nucleus raphe magnus.
    Li AH; Wang HL
    J Neurochem; 2001 Apr; 77(2):435-44. PubMed ID: 11299306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dual modulation of GIRK1/GIRK2 channels by opioid receptor ligands.
    Ulens C; Daenens P; Tytgat J
    Eur J Pharmacol; 1999 Dec; 385(2-3):239-45. PubMed ID: 10607882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonist induced homologous desensitization of mu-opioid receptors mediated by G protein-coupled receptor kinases is dependent on agonist efficacy.
    Kovoor A; Celver JP; Wu A; Chavkin C
    Mol Pharmacol; 1998 Oct; 54(4):704-11. PubMed ID: 9765514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal G-protein-gated potassium channels contribute in a dose-dependent manner to the analgesic effect of mu- and delta- but not kappa-opioids.
    Marker CL; Luján R; Loh HH; Wickman K
    J Neurosci; 2005 Apr; 25(14):3551-9. PubMed ID: 15814785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sugar solution analgesia: the effects of glucose on expressed mu opioid receptors.
    Kracke GR; Uthoff KA; Tobias JD
    Anesth Analg; 2005 Jul; 101(1):64-8, table of contents. PubMed ID: 15976207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid tolerance in periaqueductal gray neurons isolated from mice chronically treated with morphine.
    Bagley EE; Chieng BC; Christie MJ; Connor M
    Br J Pharmacol; 2005 Sep; 146(1):68-76. PubMed ID: 15980868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-selective activation of mu-oid receptor: demonstrated with deletion and single amino acid mutations of third intracellular loop domain.
    Chaipatikul V; Loh HH; Law PY
    J Pharmacol Exp Ther; 2003 Jun; 305(3):909-18. PubMed ID: 12626655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist-selective mechanisms of mu-opioid receptor desensitization in human embryonic kidney 293 cells.
    Johnson EA; Oldfield S; Braksator E; Gonzalez-Cuello A; Couch D; Hall KJ; Mundell SJ; Bailey CP; Kelly E; Henderson G
    Mol Pharmacol; 2006 Aug; 70(2):676-85. PubMed ID: 16682505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioidergic modulation of excitability of rat trigeminal root ganglion neuron projections to the superficial layer of cervical dorsal horn.
    Takeda M; Tanimoto T; Ikeda M; Kadoi J; Nasu M; Matsumoto S
    Neuroscience; 2004; 125(4):995-1008. PubMed ID: 15120859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of Ca2+ channels by heterologously expressed wild-type and mutant human micro-opioid receptors (hMORs) containing the A118G single-nucleotide polymorphism.
    Margas W; Zubkoff I; Schuler HG; Janicki PK; Ruiz-Velasco V
    J Neurophysiol; 2007 Feb; 97(2):1058-67. PubMed ID: 17151221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons.
    Rodríguez-Muñoz M; de la Torre-Madrid E; Gaitán G; Sánchez-Blázquez P; Garzón J
    Cell Signal; 2007 Dec; 19(12):2558-71. PubMed ID: 17825524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine phosphorylation of the mu-opioid receptor regulates agonist intrinsic efficacy.
    McLaughlin JP; Chavkin C
    Mol Pharmacol; 2001 Jun; 59(6):1360-8. PubMed ID: 11353794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.